ArticleCancer science2017

p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.

Xiao-Yu Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.